TikTok father or mother ByteDance hiring for AI drug discovery crew – TechCrunch

TikTok parent ByteDance hiring for AI drug discovery team – TechCrunch


ByteDance, TikTok’s Chinese language father or mother firm, is coming into the well being trade because it seeks to diversify a enterprise dependent on advertising and livestreaming sales. The corporate, which prides itself on content material algorithms, has began in search of expertise in AI drug discovery throughout Mountain View, Shanghai and Beijing, its recruiting web page shows.

“We’re searching for candidates to affix our crew and conduct cutting-edge analysis in drug discovery and manufacturing powered by AI algorithms,” one of many job postings mentioned.

The drug discovery crew, which is trying to fill not less than 5 roles together with interns, falls under the ByteDance AI Lab. The AI-focused analysis and growth arm was first established in 2016 to serve ByteDance’s content material providers like TikTok’s Chinese language model Douyin, nevertheless it’s unsurprising to see the lab extending its attain to prescription drugs, which may equally profit from the machine studying applied sciences that energy quick video feeds.

“Given the variety of analysis fields in AI, the purposes of those new applied sciences might be discovered throughout each phase of our product portfolio,” mentioned an outline on the ByteDance AI Lab website.

All 5 drug discovery analysis positions require a PhD diploma in related disciplines, equivalent to laptop science, arithmetic, computational biology and computational chemistry. Candidates will probably be engaged on drug growth equivalent to design, identification and simulation, in accordance with the postings.

ByteDance can’t be instantly reached for remark.

Different Chinese language tech behemoths have made related strikes into the well being area. Tencent’s personal AI-powered drug crew, additionally beneath the agency’s AI Lab, has been actively publishing findings since not less than August 2019. Baidu deliberate to lift $2 billion for a brand new biotech startup specializing in drug discovery and AI-powered prognosis, Reuters reported in September. Huawei has additionally made endeavors in drug discovery in addition to medical imaging by means of its cloud computing unit.



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *